您现在的位置: 首页> 研究主题> 内镜超声检查术

内镜超声检查术

内镜超声检查术的相关文献在2000年到2022年内共计73篇,主要集中在肿瘤学、内科学、临床医学 等领域,其中期刊论文66篇、会议论文7篇、专利文献496361篇;相关期刊30种,包括全科护理、护理实践与研究、中国内镜杂志等; 相关会议7种,包括2009’海峡两岸医药卫生交流与合作会议、海峡两岸立体定向肿瘤放射治疗技术论坛、首届长三角超声医学论坛暨2008上海超声医学大会、第10届解放军总医院消化内镜学术会议暨中华消化内镜学会食管胃静脉曲张出血研讨会等;内镜超声检查术的相关文献由253位作者贡献,包括金震东、李兆申、刘枫等。

内镜超声检查术—发文量

期刊论文>

论文:66 占比:0.01%

会议论文>

论文:7 占比:0.00%

专利文献>

论文:496361 占比:99.99%

总计:496434篇

内镜超声检查术—发文趋势图

内镜超声检查术

-研究学者

  • 金震东
  • 李兆申
  • 刘枫
  • 杨爱明
  • 许国铭
  • 邹晓平
  • 陆星华
  • 孙波
  • 程斌
  • 覃山羽
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

学科

年份

    • 王丹; 张华伟; 王婧
    • 摘要: 目的探讨基于JCI理念的核心问题管理模式在超声内镜检查护理流程的应用效果。方法2019年1月—2021年1月,选取在医院内镜室行超声内镜检查的140例上消化道隆起性黏膜病变患者作为研究对象,按照组间基本特征均衡可比的原则分为观察组和对照组,各70例。对照组实施常规检查流程,而观察组患者实施基于JCI理念的核心问题管理模式的检查流程,比较两组患者检查前后的焦虑情况、不良反应的发生率、护理质量和护理满意度。结果检查结束后,观察组焦虑评分低于对照组(P<0.05);观察组不良反应发生率低于对照组(P<0.05);观察组护理服务质量与患者满意程度均高于对照组(P<0.05)。结论基于JCI理念的核心问题管理模式能够改善患者在超声内镜检查中的焦虑情绪,减少患者的不良反应,并且提高护理质量和患者护理满意程度。
    • 肖军; 赵秋
    • 摘要: 2020年5月国际胰腺病学会(IAP)、美国胰腺学会(APA)、日本胰腺学会(JPS)及欧洲胰腺学会(EPC)共同发布了《2020年国际共识指南:慢性胰腺炎内镜介入治疗》.该指南基于循证医学证据,就慢性胰腺炎内镜介入治疗的适应证等9个关键临床问题提出了26项声明.本文对该指南涵盖的临床问题及声明进行要点摘译.
    • 吴巍; 范嵘; 谭继宏; 钱爱华; 程时丹
    • 摘要: 目的 探讨内镜超声检查术(EUS)对消化道黏膜下肿瘤(SMT)层次来源与性质的诊断能力及局限性.方法 2016年1月至2018年12月,收治于上海交通大学医学院附属瑞金医院消化科,术前EUS诊断为消化道SMT,接受内镜下切除术治疗,术后病理资料完整的211例病例纳入回顾性研究,以手术病理为参照,分析术前EUS诊断SMT的准确率以及EUS对SMT的诊断局限性.结果 病灶位于食管66例、胃108例、十二指肠2例、直肠35例.EUS对病变层次来源的诊断准确率达99.5%(210/211).就病变性质而言,160例EUS诊断准确(75.8%,160/211).就不同部位的病变而言,EUS对食管黏膜-黏膜下层来源、食管固有肌层来源、胃黏膜-黏膜下层来源、胃固有肌层来源、十二指肠黏膜下层来源、直肠黏膜-黏膜下层来源病变的诊断准确率分别为90.o% (54/60)、83.3% (5/6)、31.0%(13/42)、89.4% (59/66)、50.0% (1/2)、82.9% (29/35).对于EUS显示为低回声为主的病变,平滑肌瘤、平滑肌瘤/胃肠间质瘤、神经内分泌肿瘤分别是食管黏膜来源、消化道固有肌层来源和直肠黏膜-黏膜下层来源病变的较常见肿瘤类型.结论 尽管EUS对消化道SMT的诊断具有不可替代的重要作用,但其对胃黏膜-黏膜下层来源的各类病变缺乏特异的鉴别手段.由于其中部分病变可能存在恶性潜能,因此在作出诊断时需要更加谨慎.%Objective To investigate the efficacy and limitation of endoscopic ultrasonography (EUS) on the diagnosis of gastrointestinal submucosal tumor (SMT) prior to endoscopic resection.Methods Data of 211 patients,who were confirmed as gastrointestinal SMT before operation and received endoscopic resection for gastrointestinal submucosal tumor at Department of Gastroenterology,Shanghai Ruijin Hospital from January 2016 to December 2018 were analyzed.The value and limitation of EUS for SMT were investigated according to the final pathology.Results For the lesion distribution,66 were in esophagus,108 in stomach,2 in duodenum and 35 in rectum.The accuracy of tumor origin by EUS was 99.5% (210/211).The accuracy of tumor nature by EUS was 75.8% (160/211).For the lesions originated from different locations,the diagnostic accuracy for lesion originated from esophageal mucosa/submucosa,esophageal muscularis propria,gastric mucosa/submucosa,gastric muscularis propria,duodenal submucosa,rectal mucosa/submucosa by EUS were 90.0% (54/60),83.3% (5/6),31.0% (13/42),89.4% (59/66),50.0%(1/2),82.9% (29/35),respectively.With respect to hypoechoic lesions,leiomyoma,leiomyoma/gastrointestinal stromal tumor,and neuroendocrine tumor were the predominant type of tumor originated from esophageal mucosa,gastrointestinal muscularis propria and rectal mucosa/submucosal,respectively.Conclusion Although EUS is indispensible for the diagnosis of gastrointestinal submucosal tumor,it plays a limited role in the differential diagnosis of various lesions originated from gastric mucosa and submucosa.Since part of the submucosal tumors may be potential for malignant development,an diagnosis made by EUS should be more careful.
    • 吴丽权; 邓秀金; 朱薇; 郭文; 李跃; 程天明; 姚永莉; 张亚历; 刘碧旋; 钟慕晓; 李思南
    • 摘要: 目的 探讨预测胰腺导管腺癌(PDAC)鉴别于胰腺其他实性肿瘤病变的因素,评估内镜超声引导下细针抽吸术(EUS-FNA)对PDAC的诊断价值.方法 回顾性分析2009年1月~2016年5月南方医科大学南方医院消化内窥镜中心因胰腺占位行EUS-FNA检查的患者的临床资料,排除诊断不明、资料缺失、重复穿刺、囊性占位病变以及良性病变病例,将患者分为PDAC组与non-PDAC组,比较两组的EUS-FNA穿刺阳性率,统计EUS-FNA对PDAC诊断的敏感度、特异度、阳性预测值、阴性预测值和准确率,纳入PDAC组和non-PDAC组患者的人口特征、临床特征、实验室检查和超声内镜成像特征等相关因素进行单因素和多因素非条件logistic回归分析.结果 纳入75例胰腺实体肿瘤病变中,PDAC占72.0%,non-PDAC占28.0%.EUS-FNA诊断PDAC的敏感度、特异度、阳性预测值、阴性预测值和准确率分别是77.8%、100.0%、100.0%、63.6%、84.0%.PDAC组与non-PDAC组的EUS-FNA穿刺阳性率差异无统计学意义(77.8%vs 76.2%,P>0.05).多因素logistic分析显示腹痛(OR=5.163,95%CI:1.093~24.389,P=0.038)、病灶性状(OR=7.105,95%CI:1.440~35.043,P=0.016)、病灶大小(OR=0.926,95%CI:0.877~0.978,P=0.006)、病灶转移(OR=6.165,95%CI:1.332~28.533,P=0.020)是预测PDAC的独立影响因子.结论 腹痛、病灶转移、病灶大小和病灶性状的超声内镜成像特征可以可靠地预测PDAC,并且EUS-FNA对PDAC的诊断是具有较高的敏感度和特异度.
    • 朱秀琴; 胡兰
    • 摘要: [目的]总结内镜超声引导下细针抽吸活检术(EUS-FNA)在上消化道壁外(胰腺、纵膈、腹膜后)占位性病变中的应用及护理,以提高该技术的安全性和成功率.[方法]对我院2015年-2016年间开展的75例EUS-FNA病人进行回顾性分析总结.[结果]75例病人均穿刺成功,无严重并发症,获得满意的病理结果.[结论]EUS-FNA对上消化道壁外占位病变的诊断是一种安全、准确、有效的方法,术前做好充分的病情评估和针对性的心理护理,术中做好操作细节的配合,术后严密观察病情变化,规范处理穿刺标本并专人送检,及时发现并处理并发症是保证成功的重要环节.
    • 张超; 武希润; 史美琴; 王海英
    • 摘要: 原发性胃弥漫大B细胞淋巴瘤(PG-DLBCL)是指原发于胃肠道的非霍奇金淋巴瘤,该病的早期临床表现缺乏特异性,易被误诊,在治疗反应以及预后中具有显著的生物学异质性.近年来PG-DLBCL的发病呈明显增高趋势,而国内外对该病的报道大多局限于回顾性分析及个案报道,希望通过探讨最新的诊疗技术及治疗进展,能提高临床对该病的认识,减少误诊,为改善患者的预后提供更好的治疗方案.
    • 刘香; 李仁春; 郭瑾陶; 王晟; 葛楠; 王国鑫; 孙思予
    • 摘要: Objective To investigate the value of endoscopic ultrasonography for the diagnosis and treatment of esophageal submucosal lesion.Methods Clinical data of 589 patients who underwent endoscopic treatment of esophageal submucosal lesion in Shengjing Hospital from January 2013 to January 2015 were reviewed,and the characteristics of endoscopic ultrasonography and pathological findings in patients were analyzed.Results In the esophageal subepthelial lesions,leiomyoma was the most common,accounting for 93.2% (549/589),other pathological types are rare.Endoscopic ultrasonography of esophageal leiomyoma showed homogeneous low echo mass,clear boundary,originated from the second or fourth layer of the wall.In 589 cases,endoscopic ultrasound diagnosis was consistent with pathology in 570 cases,but not in 19 cases.The diagnostic consistency was 96.6%.Conclusion Endoscopic ultrasonography can accurately and clearly show the layer of the digestive tract wall,the origin,range and size of subcutaneous lesions in the upper digestive tract,which indicates the nature of the lesions,and is of diagnostic value for further treatment.%目的 探讨内镜超声对食管黏膜下病变的诊断和治疗应用价值.方法 回顾性研究2013年1月至2015年1月在中国医科大学附属盛京医院食管黏膜下病变行内镜下治疗的589例患者的临床资料,对其内镜超声特点及病理结果进行全面总结分析.结果 食管黏膜下病变中,平滑肌瘤最常见,占总数93.2%(549/589),其他病理类型比较少见.食管平滑肌瘤EUS下表现为均质低回声肿块,边界清晰,起源管壁第二或四层.589例患者中内镜超声与病理诊断符合570例,不符合19例,诊断符合率为96.6%.结论 内镜超声能准确清楚显示消化道壁的层次结构和壁外情况,判断消化道黏膜下病变的起源、范围及大小,并能够提示病变的性质,对进一步的治疗有指导意义.
    • 覃山羽; 刘芷玲; 姜海行; 罗薇; 胡榜利; 宁红建; 陶霖; 苏思标; 覃凤燕
    • 摘要: 目的:探讨内镜超声引导下无水乙醇注射治疗良性胰岛素瘤的安全性及有效性。方法采用前瞻性设计观察自2013年12月至2015年1月广西医科大学第一附属医院收治的10例通过内镜超声引导下细针穿刺病理活检确诊为良性胰岛素瘤患者的研究结果。结果在内镜超声引导下通过细针穿刺病灶处注射0.10~2.00 ml(0.70±0.62 ml)无水乙醇共进行15次治疗,术中、术后均未出现并发症,术后血糖水平较术前升高[4.8(3.9~5.5)mmol/ L 比2.4(1.9~2.5)mmol/ L,P<0.05];胰岛素水平显著降低[83.7(40.1~143.5)pmol/ L 比177.3(66.5~200.6)pmol/ L,P<0.05]。术后平均住院日为(4.3±1.5)d。术后随访(6个月~1年)内镜超声可见病灶随时间推移回声较前明显减低,而超声造影呈低增强、乏血供改变。结论内镜超声引导下无水乙醇注射治疗良性胰岛素瘤安全、有效,有可能是一种新的微创治疗方法。临床试验注册美国临床试验中心,NCT02121366%Objective To evaluate the safety and efficacy of endoscopic ultrasonography(EUS) guided ethanol ablation in patients with insulinoma. Methods The data of 10 patients with insulinoma trea-ted at the First Affiliated Hospital of Guangxi Medical University from December 2013 to January 2015 were prospectively analyzed. Results The patients were given EUS-guided ethanol ablation with dose of 0. 10 to 2. 00 ml(average 0. 70 ± 0. 62 ml)in pancreatic lesions for 15 times. No complications were observed dur-ing and after the procedure. The blood glucose improved after the procedure[4. 8(3. 9-5. 5)mmol/ L VS 2. 4 (1. 9-2. 5)mmol/ L,P < 0. 05]and the serum insulin level significantly decreased[83. 7(40. 1-143. 5) pmol/ L VS 177. 3(66. 5-200. 6)pmol/ L,P<0. 05]. The average hospital stay was(4. 3±1. 5)days. The patients were followed up for 6-12 months. EUS indicated that the echo of pancreatic lesions changed from high to low. CE-EUS revealed low enhancement and lack of blood supply. Conclusion EUS-guided ethanol ablation may become a promising minimally invasive treatment for insulinoma because of its safety,efficacy and low price. Trail registration Clinical Trial.gov,NCT02121366.
    • 刘渊; 杨秀疆; 孙波; 张文明; 张召珍; 贺益萍
    • 摘要: 目的:通过与 CT、B超、MRI及 PET/CT 进行比较,评估 EUS 对胰腺神经内分泌瘤( pNETs)的诊断价值。方法2012年7月至2016年3月,复旦大学附属肿瘤医院行EUS检查且病理确诊的70例pNETs患者(77个病灶)纳入回顾性研究,并对其中有外科手术病理的53例患者(60个病灶)的手术前EUS、B超、CT、MRI、PET/CT检查结果进行统计分析。结果 EUS共检出76个病灶,当中32个<2 cm的病灶使用了高清精细放大功能,49个病灶获得了符合质量的弹性成像图,42个实性病变或实性成分加测了精细血流,6例采用了3D成像功能。 pNETs的EUS、B超、CT、MRI、PET/CT检出率分别为9833%(59/60)、6111%(33/54)、8947%(51/57)、7600%(19/25)、7838%(29/37),其中<2 cm 病灶的检出率分别为9630%(26/27)、4783%(11/23)、7600%(19/25)、5455%(6/11)、5882%(10/17);pNETs病变部位的EUS、B超、CT、MRI、PET/CT判断准确率分别为9167%(55/60)、5185%(28/54)、8070%(46/57)、7200%(18/25)、7568%(28/37)。结论通过应用精细血流、高清精细放大及弹性成像等功能,EUS对于pNETs尤其是<2 cm的pNETs的诊断较传统影像学方法更有优势。%Objective To study the diagnostic value of endoscopic ultrasonography( EUS) for pan⁃creatic neuroendocrine tumors ( pNETs) by comparing EUS with computed tomography ( CT) , ultrasonogra⁃phy, magnetic resonance imaging ( MRI ) and positron emission tomography/computed tomography (PET/CT). Methods Data of 70 pNETs cases (a total of 77 lesions) confirmed by pathological diagnosis from July 2012 to March 2016 in Shanghai Cancer Center of the Fudan University were retrospectively stud⁃ied. Among the cases, 53 cases ( a total of 60 lesions) were confirmed by surgical pathology and their results of EUS, abdominal ultrasonography, CT, MRI and PET/CT were compared before surgery. Results A total of 76 lesions were detected by EUS, in which 32 lesions less than 2 cm were tested by HI ZOOM high defini⁃tion amplification, qualified elastography images of 49 lesions were obtained, 42 solid lesions or solid compo⁃nents were also tested by Fine Flow, and 6 cases were tested by 3D imaging. Diagnostic rates of lesions by EUS, ultrasonography, CT, MRI and PET/CT were 9833% (59/60), 6111%(33/54), 8947%(51/57), 7600%(19/25) and 7838%(29/37), respectively. For lesions less than 2 cm, diagnostic rates by these ex⁃aminations were 9630% ( 26/27 ) , 4783%( 11/23 ) , 7600%( 19/25 ) , 5455%( 6/11 ) and 5882%(10/17), respectively. Accuracy rates of EUS, ultrasonography, CT, MRI and PET/CT in the location of these lesions were 9167%(55/60), 5185%(28/54), 8070%(46/57), 7200%(18/25) and 7568%(28/37), respectively. Conclusion Combined with Fine Flow, HI ZOOM high definition amplification and elastography, EUS is superior to standard imaging for pNETs, especially for lesions less than 2 cm.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号